TRUPANION, INC. (TRUP) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $2.4M sold). Latest close $36.68 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.
Greenlea Lane Capital — 1 tracked fund hold TRUP. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 13 sales ($2.4M). Insider trading
Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Greenlea Lane Capital | 5.28% | 776,490 | HELD Q3 filed Nov 16 |
| Maverick Capital | — | — | EXITED |
| Check Capital Management | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +39.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 200 of 8,857 filers |
| Long-only filers among them | 199 |
| Change vs 2026 Q1 | +6 net · 192 entered · 186 exited |
| Shares reported, all filers | 33,737,199 |
| Reported value, all filers | $828.1M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Hospital & Medical Service Plans (SIC 6324) |
| Revenue · FY2025 | $1.4B |
| Net income · FY2025 | $19.4M |
| Total assets · FY2025 | $915.0M |
| Shares outstanding | 43,872,611 |
| Market cap (at latest close) | $1.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 29, 2026.
| Shares short · Oct 15, 2026 | 3,676,788 |
| Share of shares outstanding | 8.38% |
| Days to cover | 9.31 |
Shares short at recent settlements — Jul 31, 2026: 3.7M · Aug 14, 2026: 4.0M · Aug 31, 2026: 4.0M · Sep 15, 2026: 4.1M · Sep 30, 2026: 3.9M · Oct 15, 2026: 3.7M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 29, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 91 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 29, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 13 sales by 5 insiders ($2.4M).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | RUBIN HOWARD E | Sell | 10,000 | $35.57 | $355.7K | SEC filing | |
| Nov 13, 2026 | RUBIN HOWARD E | Sell | 10,000 | $34.50 | $345.0K | SEC filing | |
| Nov 10, 2026 | LOW MURRAY B | Sell | 6,537 | $34.21 | $223.6K | SEC filing | |
| Nov 9, 2026 | Tooth Margaret | CEO | Sell | 1,900 | $36.44 | $69.2K | SEC filing |
| Nov 9, 2026 | Tooth Margaret | CEO | Sell | 100 | $36.92 | $3.7K | SEC filing |
| Nov 9, 2026 | RUBIN HOWARD E | Sell | 30,000 | $35.23 | $1.1M | SEC filing | |
| Oct 28, 2026 | GALLAGHER JOHN R | Chief Operating Officer | Sell | 431 | $29.12 | $12.6K | SEC filing |
| Oct 9, 2026 | Tooth Margaret | CEO | Sell | 1,000 | $25.84 | $25.8K | SEC filing |
| Sep 28, 2026 | GALLAGHER JOHN R | Chief Operating Officer | Sell | 431 | $22.92 | $9.9K | SEC filing |
| Sep 11, 2026 | Tooth Margaret | CEO | Sell | 1,000 | $25.00 | $25.0K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | MARGARET R TOOTH | Officer, Director | 1,000 | $25.8K | Oct 9, 2026 | SEC filing |
| Sep 28, 2026 | JOHN GALLAGHER | Officer | 431 | $9.9K | Sep 28, 2026 | SEC filing |
| Sep 11, 2026 | MARGARET R TOOTH | Officer, Director | 1,000 | $25.0K | Sep 11, 2026 | SEC filing |
| Aug 28, 2026 | JOHN GALLAGHER | Officer | 3,604 | $107.0K | Aug 28, 2026 | SEC filing |
| Aug 26, 2026 | FAWWAD QURESHI | Officer | 6,111 | $183.4K | Aug 26, 2026 | SEC filing |
| Aug 11, 2026 | MARGARET R TOOTH | Officer, Director | 978 | $28.4K | Aug 11, 2026 | SEC filing |
| Jul 28, 2026 | JOHN GALLAGHER | Officer | 431 | $10.8K | Jul 28, 2026 | SEC filing |
| Jun 29, 2026 | JOHN GALLAGHER | Officer | 431 | $10.9K | Jun 29, 2026 | SEC filing |
| Jun 5, 2026 | STEVE A WEINRAUCH | Officer | 6,674 | $146.8K | Jun 5, 2026 | SEC filing |
| May 28, 2026 | JOHN GALLAGHER | Officer | 3,603 | $78.2K | May 28, 2026 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 25, 2026 | Tarmac DLTFM Ltd | SC 13G/A | 0 | 0.0% | Feb 17, 2026 | SEC filing |
| Feb 24, 2026 | FELIX HOLDINGS BV | SC 13G | 4,296,538 | 9.9% | Feb 17, 2026 | SEC filing |
| Oct 10, 2025 | Tarmac DLTFM Ltd | SC 13G/A | 3,575,538 | 8.3% | Oct 11, 2023 | SEC filing |
| Aug 12, 2025 | Wellington Management Group LLP | SC 13G/A | 2,038,458 | 4.8% | Jun 30, 2025 | SEC filing |
| Feb 10, 2025 | Wellington Management Group LLP | SC 13G/A | 2,200,537 | 5.2% | Dec 31, 2024 | SEC filing |
| Feb 4, 2025 | FLOSSBACH VON STORCH SE | SC 13G | 0 | 0.0% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· Top Relative Strength — Top 20% of the universe by 6-month return
Key figures
· Growth — Latest revenue: $1.4B · 5-yr revenue CAGR: 23.4% · Straight growth years: 13
· Cash Flow (FCF) — Latest FCF: $75.4M · FCF yield: 5.7% · Positive FCF years: 3
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 1 | 100.0% | +38.1% | +12.1% | +26.0% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold TRUP — ranked by lift, the co-holding pattern described in Methodology: Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) · Oscar Health, Inc. (OSCR) · PROGRESSIVE CORP/OH/ (PGR) · Chubb Ltd (CB).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 5, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Aug 5, 2026 | 2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
| Jun 15, 2026 | 5.07 Submission of Matters to a Vote of Security Holders | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Elevance Health, Inc. (ELV) · Track Record: how the signals scored · Practice timing on TRUP
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.